View in EDS HTML Full Text PDF Full Text

Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain.

Saved in:
Bibliographic Details
Title: Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain.
Authors: Nieto‐Cid, María1,2 (AUTHOR), Garriga‐Baraut, Teresa3 (AUTHOR), Plaza‐Martín, Ana Mª.4 (AUTHOR), Tortajada‐Girbés, Miguel5,6,7 (AUTHOR), Torres‐Borrego, Javier8 (AUTHOR), Lozano‐Blasco, Jaime4 (AUTHOR), Moreno‐Galarraga, Laura9 (AUTHOR), del Mar Folqué‐Giménez, Mª.4 (AUTHOR), Bosque‐García, Montse10 (AUTHOR), Gaboli, Mirella11 (AUTHOR), López‐Neyra, Alejandro12 (AUTHOR), Rivas‐Juesas, Cristina13 (AUTHOR), Caballero‐Rabasco, Mª. Araceli14 (AUTHOR), Freixa‐Benavente, Andrea3 (AUTHOR), Valdesoiro‐Navarrete, Laura10 (AUTHOR), de Mir‐Messa, Inés3 (AUTHOR), Ballester‐Asensio, Esther5,6 (AUTHOR), Penín‐Antón, María15 (AUTHOR), Romero‐García, Raquel16 (AUTHOR), Navarro‐Morón, Juan17 (AUTHOR)
Source: Pediatric Allergy & Immunology. Apr2023, Vol. 34 Issue 4, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09056157
DOI:10.1111/pai.13942